OBJECTIVES: Since 1996, our centre performs restrictive enlargement of the pulmonary annulus at surgical repair of tetralogy of Fallot. A transannular patch is only used if the z-score of the pulmonary annulus is smaller than -2. We sought to determine whether this strategy reduces pulmonary insufficiency (PI) and reoperation rate compared to a nationwide contemporary cohort that has not been operated using a uniform strategy.
INTRODUCTION
Right ventricular (RV) dilatation, caused by pulmonary insufficiency (PI), is one of the major causes of heart failure, malignant arrhythmia and sudden cardiac death in patients with repaired tetralogy of Fallot (ToF) [1, 2] . Previous publications showed that the use of a transannular patch (TAP) during ToF repair aggravates PI [3, 4] . Since 1996, we therefore follow a uniform strategy which aims at limiting the use of a TAP. Since data showed that RV pressure is not significantly elevated even if the postoperative z-score of the pulmonary annulus (PA) is close to -4, the use of a TAP is only intended in patients with a pulmonary annulus diameter (PAD) of less than a z-score of -4 [3] . If a TAP is necessary, enlargement of the PA is limited to the lowest normal value of a z-score of -2. Ten years after introducing this strategy we were able to show that this strategy lowers TAP rate, limits the postoperative width of the PA but does not result in increased RV pressure load or reoperation rate for residual right ventricular outflow tract (RVOT) obstruction [5] . We hypothesize that this strategy leads to a reduction in PI with subsequent RV dilatation and reoperation rate in the intermediate term. We therefore conducted a follow-up study assessing outcome in terms of freedom from reoperation of the pulmonary valve, RVOT or main pulmonary artery (MPA). RV size and PI were measured using cardiovascular magnetic resonance (CMR) imaging. Results of our cohort were compared to a German nationwide cohort of ToF patients who was not operated following a uniform strategy [6] .
MATERIALS AND METHODS

Study group
Ninety-eight patients with ToF underwent complete surgical repair between 1996 and 2006 at the University Hospital of SchleswigHolstein, Campus Kiel, Germany. All patients were operated on by a single surgeon (J.S.). Patients with pulmonary atresia, absent pulmonary valve, double outlet right ventricle and patients in whom homograft placement to reconstitute RV to pulmonary artery continuity was necessary, were excluded from the study. The parents of all patients gave their informed consent for all examinations and anonymized analysis of the data. The study was approved by the local research ethics committee (ethics approval number A 129/15).
Uniform surgical strategy of restrictive enlargement of the pulmonary annulus at tetralogy of Fallot repair
Complete surgical procedure of the uniform strategy was described previously [5] . Briefly, the approach of restrictive enlargement of the PA and RVOT is described. To achieve a wide RVOT, we performed an extensive infundibulectomy by resection of muscle bundles, thinning out and also digging a trench. Hegar dilators were used to assess the size of the pulmonary valve opening. If the commissures were found to be fused on inspection, careful pulmonary valvotomy was carried out. In case of a bicuspid valve with a 9-3 o'clock disposition the anterior leaflet was cut and fixed to the pulmonary artery wall or the patch.
The surgical strategy was to insert a TAP only in patients where the PAD was still below a z-score of -4 after pulmonary valvotomy [5] . The z-scores were taken from the normative angiographic data by Sievers et al in conjunction with comparable data from Sairanen et al. [7, 8] . When using a TAP it was aimed to spare the valve leaflets by opening the PA through a commissure to limit postoperative PI. The width of the TAP was tailored to restrict the PAD to a z-score of -2 using an accordingly sized Hegar dilator in the RVOT for guidance.
The size of the MPA was aimed to be around the mean diameter for body size. If there was a buckle formation in the left pulmonary artery, it was generously cut into to achieve an unobstructed flow. Altogether this approach is named as restrictive enlargement of the PA in this article.
Clinical, echocardiographic and surgical data
We recorded and analysed the last outpatient visits for all patients in the period from 1 January 2013 until 31 August 2015. Data was collected from the patients' records and the hospital data system. Pertinent patient data included age, follow-up time since ToF repair, age at ToF repair, gender and New York Heart Association functional class. Data on the type of ToF repair, primary palliation with a shunt and intraoperative pressures were collected from operation notes. Reoperations were classified as (i) reoperations of the RVOT, PV or MPA or (ii) others.
Echocardiographic data was either taken from the hospital data base or from patients' records. The maximal RVOT/PV flow velocity (Vmax) was measured and expressed as meters per second. Residual RVOT obstruction (RVOTO) was defined as a Vmax >2.5 m/s. PI was graded subjectively (1 = absent or trivial, 2 = mild, 3 = moderate and 4 = severe). Width of the QRS complex was taken from patients' records.
Cardiovascular magnetic resonance imaging
If no late postoperative CMR was performed, patients were prospectively recruited to be studied with CMR. CMR studies were performed on a MR system (1.5 and 3.0 Tesla, Achieva, Philips Healthcare, Best, Netherlands) using a 16 and 32 channels XL SENSE Torso/Cardiac surface coil (Philips Healthcare, Best, Netherlands). Phase-contrast cine MR imaging was performed to evaluate through-plane flow measurements in the MPA. A dedicated cardiac software tool (Extended MR WorkSpace, version 2.6.3.5,2013, Philips Healthcare, Best, Netherlands) was used to calculate pulmonary systolic forward flow and regurgitation fraction. For assessment of RV size and function electrocardiogram-gated cine images in sagittal slice orientation were obtained using a gradient-echo cine sequence during expiratory breath-hold with the following sequence parameters: voxel size, 1.1 Â 1.1 Â 6-8 mm and cardiac phases 25. The images were analysed with the above-mentioned dedicated software.
For patients who needed a reoperation of the PV, RVOT or MPA, CMR studies before the first reoperation were included in the study. If CMR was performed after reoperation the data were excluded from the study.
Control group
The data of our cohort (Group 1) was compared to a German nationwide cohort of ToF patients who were not operated using a uniform strategy (Group 2), which was retrieved from the Competence Network for Congenital Heart Disease. Data of this cohort have been previously collected and published by Sarikouch et al. [6, 9] . In a multi-centre setting, ToF patients aged >8 years were recruited for CMR between 2005 and 2008. The cohort consists of 407 patients from 14 centres in Germany who were operated between 1991 and 2000. In order to compare the groups, we limited the nationwide cohort to patients who fulfilled the following criteria: The extreme variant of ToF with pulmonary atresia was excluded. Patients who needed a RV to pulmonary artery conduit during ToF repair were also excluded. Since the oldest patient in our cohort was repaired at the age of 3.7 years, patients who were >3.7 years at ToF repair were excluded from Group 2. All patients where information on TAP insertion was missing were excluded. Written informed consent was obtained from all the patients or their caregivers.
Statistical analysis
Data is expressed as mean ± standard deviation or median (minimum and maximum) as appropriate. Results for each variable were tested for normality using the Kolmogorov-Smirnov method. Comparisons between groups were made with Student's t-test, Mann-Whitney test or v2 test as appropriate. Freedom from reoperation was calculated using the Kaplan-Meier survival analysis with log-rank test for comparison of survival curves. Patients who did not experience the primary outcome were censored at the time of last follow-up. Cox proportional hazards regression was used to evaluate factors associated with time until the primary outcome. Variables with a P-value of 0.1 or less on univariate analysis were entered in a stepwise model with forward selection. Hazard ratios are reported with 95% confidence intervals (CI). For all analyses, a P-value < 0.05 was considered statistically significant. Statistical analysis was performed with MedCalc software (version 14.12, Mariakerke, Belgium).
RESULTS
Patient characteristics and clinical status
We identified 88 patients from our cohort and 167 from the control group who met the inclusion criteria. Patient characteristics are summarized in Table 1 . One patient in our cohort died of a non-cardiac cause. Only survivors were included in the control group, so mortality cannot be assessed. Follow-up time since ToF repair was not different between the groups. In Group 1, age at repair was lower, more patients were in New York Heart Association Class I and the QRS complex was narrower. Group 1 showed a tendency towards more palliative shunt procedures before repair. In our cohort, an intraoperative revision for residual RVOTO was necessary in 11 patients (12.6%) of which 5 patients needed secondary patch enlargement but only 2 received a TAP (2.3%). Invasive pressures were measured at the end of the operation, mean left ventricular/RV pressure ratio was 0.55 ± 0.12 with a mean RV pressure of 43.1 ± 9.2 mmHg and a mean RVOT gradient of 17.5 ± 8.0 mmHg and a Vmax in postoperative echocardiography of 2.3 ± 0.7 m/s. Follow-up echocardiographic data was available in 158 of 167 patients in Group 2 and in all patients in Group 1. Maximum velocity in the RVOT and PV was higher in Group 1 (Table 1 ) and more patients had residual RVOTO. In our cohort maximum velocity in the RVOT did not change over time (P = 0.29). More patients in the control group showed moderate or severe PI (Fig. 1) .
Outcome
The TAP rate was lower in our cohort and significantly less reoperations of the RVOT, PV or MPA were performed (Table 1) . Other reoperations included closure of a residual ventricular septal defect (8), repair of partial anomalous pulmonary venous connection (1) and repair of peripheral pulmonary artery stenosis (2). More patients in Group 2 needed a reoperation for PI, while the reoperation rate for pulmonary stenosis (PS) was not different in the groups. In both groups some patients had a combined PS and PI and are therefore listed in both categories. In the control group, indication for reoperation was missing in 6 patients. Overall 44 patients (17.3%) underwent pulmonary valve replacement (PVR) with significantly more patients belonging to Group 2. Using Kaplan-Meier analysis, freedom from reoperation at 10 and 15 years was 92% and 79% in Group 1 and 86% and 64% in Group 2 (P = 0.01), respectively (Fig. 2) . Concerning the indication for reoperation, univariate log-rank test showed that reoperation for PS was not influenced by surgical strategy (P = 0.88) whereas there was a higher rate of reoperations for PI in the control group (hazard ratio 2.67, 95% confidence interval 1.39-5.08; P = 0.01) (Fig. 3) .
On univariate analysis, TAP and surgical strategy (restrictive enlargement of the PA) were associated with the outcome, while age at ToF repair and operative period (1 = before 1995, 2 = 1996-2001, 3 = after 2001) were not associated with reoperation ( Table 3) . In a multivariable analysis including surgical strategy, operative period and TAP only surgical strategy was an outcome predictor.
Cardiac magnetic resonance imaging
In both groups, CMR data obtained after reoperation were excluded. Fifty-four CMR datasets of Group 1 could be included. Since the control group was originally recruited for a CMR study 134 datasets could be included. To ascertain that the results are representative for the whole study group, we checked for TAP rate, which was not different in the subgroups of patients who had a CMR and the main groups (all patients vs CMR patients: Group 1: 32.2% vs 33.3%, P = 0.97; Group 2: 64.7% vs 65.7%, P = 0.95). CMR data are given in Table 2 . Indexed RV volumes were significantly higher in Group 2, while ejection fraction and muscle mass were not different. Pulmonary regurgitation fraction was significantly higher in Group 2.
DISCUSSION
In 1996, our centre started following a uniform strategy of restrictive enlargement of the PAD. We were able to show that the extent of PI correlates with the postoperative size of the PA and that even a small PAD between the second and fourth lower standard deviation sufficiently unloads RV pressure [3] . After 10 years, we compared our results to a historic cohort and found a decrease in TAP rate from 68% to 32% [5] . None of the patients with a PAD z-score above -2 received a TAP and mean postoperative PAD was significantly reduced. The current study collected intermediate-term follow-up data of this cohort and compared them to a nationwide cohort with the same follow-up period. Data of the control group was already collected in 2009 so that the period of ToF repair does not completely overlap. Current data from the German quality assurance for congenital heart disease shows a TAP rate of 62.8% in 172 ToF repairs in 2014 [10] . Since the TAP rate in the control group is 64.7% we feel that it still represents current surgical practice in Germany and therefore sufficiently serves as a control group. Moreover, we found no association between operative period and reoperation rate, which supports this notion.
Reoperation rate
The rate of reoperations of the PV, RVOT and MPA was significantly lower in patients who were operated following restrictive enlargement of the PA at ToF repair. Since TAP rate was significantly lower in our cohort and in univariate analysis TAP was a predictor for reoperation, one might easily attribute the favourable outcome to the reduction in TAP rate alone. Yet the focus of our surgical strategy has been to limit the size of the PAD, whether a TAP was implemented or not. Consequently multivariable analysis revealed a stronger impact of the restrictive enlargement of the PA on freedom from reoperation than the use of a TAP alone. This result of our study confirms the single centre data from Simon et al. where the use of a limited TAP, compared to patients without a TAP, did not result in a higher reoperation rate at an intermediate-term follow-up of 8 years [11] . The centre used a similar approach to ToF repair where a limited TAP is only used in patients with a PAD below the z-score of -2.5 and postoperative PAD was limited to a z-score between -1.0 and 0. On the other hand, Luijten et al. [12] showed that if a TAP is used without restricting the postoperative PAD, it is a predictor for poorer event-free outcome. In a large Australian study d'Udekem et al. [13] looked for intersurgeon variability in long-term outcomes after transatrial repair of ToF and concluded that an optimal amount of opening of the RVOT can lead to a decreased reintervention rate. Consequently Kaplan-Meier analysis of our data showed that freedom from reoperation was superior in patients who were operated following uniform restrictive enlargement of the PA compared to the nationwide cohort.
More patients in the nationwide cohort needed pulmonary valve replacement. Even though policies for the indication for PVR exist [14, 15] , controversies regarding the optimal timing of PVR remain [16, 17] . With growing knowledge about RV remodelling our centre has followed the general recommendations for decision-making according to CMR volumetric data [18, 19] . Due to the retrospective nature of the study and the multicentre setting a strong conformity in decision-making may not be given. However the 4-fold higher percentage of patients who received PVR in the nationwide cohort cannot primarily be ascribed to discrepancies in decision-making, but rather by the restrictive enlargement of the PA at ToF repair in our cohort.
Pulmonary insufficiency and right ventricular dilatation
In 2010, data from the Society of Thoracic Surgeons Database on contemporary patterns of management of ToF showed that ventriculotomy with TAP remains the most prevalent technique [19, 20] . This statement is in agreement with our finding that TAP rate was higher in the control group and more patients had moderate or severe PI. Accordingly, CMR showed significantly higher pulmonary regurgitation fraction and RV volumes in the control cohort. Already at intermediate follow-up, freedom from reoperation for PI was lower in the control group. Unfortunately other well-known sequelae of PI and RV dilatation, arrhythmia and exercise intolerance were not studied. However, even in patients who have been operated decades ago using classical repair strategies, these often occur late after ToF repair [1] . Therefore these parameters should be addressed at later follow-up investigations of our cohort.
Obstruction of the right ventricular outflow tract
The compromise of the restrictive strategy may be residual RVOTO and need for reoperation for stenosis. In our cohort, 12.6% of patients needed intraoperative revision for residual RVOTO, but only 2.3% received a TAP during revision. The RV/ left ventricular pressure ratio proofs that the restrictive approach is able to sufficiently unload the RV from pressure, which has already been shown by Uebing et al. [3] . However Bove et al. [21] showed an increase in early reoperation rate for RVOTO using an infundibulum sparing approach. On the contrary our group reported a similar incidence of early reoperation in our cohort compared to a historic cohort [5] . The data presented here confirm this result; the reoperation rate for PS was not different from the national control cohort. Kaplan-Meier analysis found no difference in freedom from reoperation for PS over the whole study period, even though the curve shows more reoperations in our cohort within the first year after repair. As expected, late echocardiography shows a higher residual gradient in the RVOT in our cohort compared to the control group, yet the RVOT gradient didn't change significantly since the first postoperative echocardiography. Commonly a gradient >25 mmHg has been described as residual RVOTO [22, 23] and there is a trend towards more patients with RVOTO in our group. Next to the negative impact that RVOTO might have on early reoperations, there seems to be a beneficial effect. Latus et al. [24] postulate a protective effect of RVOTO on RV remodelling, as it seems to preserve RV strain and results in stronger RV-left ventricular interactions and less interventricular dyssynchrony. The optimal range of RVOTO after repair has yet to be defined.
Limitations
The retrospective nature of the study results in a considerable amount of missing information. Incomplete information on associated cardiac malformations and genetic syndromes of the control group forbids analysis of this data. Surgical strategies of the participating institutions in the competence network for congenital heart disease are not specifically known. These are most likely multiform, cover the complete range of ToF repair and thus represent an average of surgical management. Moreover the criteria for reoperation for residual RVOTO might be different between centres as there was no prospective agreement on timing of a reoperation.
CONCLUSIONS
Ten-year follow-up shows that ToF patients operated following a uniform strategy of restrictive enlargement of the PA have a lower risk for reoperation compared to a contemporary German nationwide cohort. The incidence of moderate or severe PI is significantly lower and consequently RV volumes measured by CMR are smaller. Multivariable analysis showed that restrictive enlargement of the PA has a stronger influence on freedom from reoperation than the use of a TAP itself. Late consequences of PI due to implementation of a TAP are widely recognized but more attention should be payed to sizing the patch size and limiting the postoperative PAD during repair.
